Botulinum toxin therapy of laryngeal muscle hyperactivity syndromes: Comparing different botulinum toxin preparations

European Journal of Neurology

Volumn 13, Issue SUPPL. 1, 2006, Pages 36-41

  Truong, D D ^a   Bhidayasiri, R ^a,b,c  

^a Parkinson's and Movement Disorder Institute   (United States)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

Abductor spasmodic dysphonia; Adductor spasmodic dysphonia; Botulinum toxin; Laryngeal spasmodic dyspnea; Voice tremor; Voice tremors

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; XEOMIN;

AIRWAY OBSTRUCTION; BLEPHAROSPASM; BREATHING DISORDER; CONFERENCE PAPER; DYSPHAGIA; DYSPNEA; DYSTONIA; HOARSENESS; HUMAN; INJECTION; LARYNGEAL MUSCLE HYPERACTIVITY SYNDROME; LARYNX; LARYNX DISORDER; MUSCLE; PATIENT SATISFACTION; PRIORITY JOURNAL; SPASMODIC DYSPHONIA; SPASMODIC LARYNGEAL DYSPNEA; THYROID GLAND; TREMOR; VOCAL CORD DISORDER; WHEEZING;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DRUG ADMINISTRATION ROUTES; DYSTONIC DISORDERS; HUMANS; HYPERKINESIS; LARYNGEAL DISEASES; LARYNGEAL MUSCLES; LARYNX; TREATMENT OUTCOME;

EID: 33645106313     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01443.x     Document Type: Conference Paper

References (65)

1. Heaver L Spastic dysphonia: A psychosomatic voice disorder In Thomas CC ed Psychological and Psychiatric Aspects of Speech and Hearing Springfield D. A. Barbara 1960 pp. 250 253
2. Aronson AE Brown JR Litin EM Pearson JS Spastic dysphonia. II. Comparison with essential (voice) tremor and other neurologic and psychogenic dysphonias Journal of Speech and Hearing Disorders 1968 33 219 231
3. Aronson AE Brown JR Litin EM Pearson JS Spastic dysphonia. I. Voice, neurologic, and psychiatric aspects Journal of Speech and Hearing Disorders 1968 33 203 218
4. Leonard R Kendall K Differentiation of spasmodic and psychogenic dysphonias with phonoscopic evaluation Laryngoscope 1999 109 295 300
5. Adler CH Edwards BW Bansberg SF Female predominance in spasmodic dysphonia Journal of Neurology Neurosurgery and Psychiatry 1997 63 688
6. Schweinfurth JM Billante M Courey MS Risk factors and demographics in patients with spasmodic dysphonia Laryngoscope 2002 112 220 223
7. Greene P Kang UJ Fahn S Spread of symptoms in idiopathic torsion dystonia Movement Disorders 1995 10 143 152
8. Aronson AE Hartman DE Adductor spastic dysphonia as a sign of essential (voice) tremor Journal of Speech and Hearing Disorders 1981 46 52 58
9. Sapienza CM Walton S Murry T Acoustic variations in adductor spasmodic dysphonia as a function of speech task Journal of Speech Language and Hearing Research 1999 42 127 140
10. Ludlow CL Connor NP Dynamic aspects of phonatory control in spasmodic dysphonia Journal of Speech and Hearing Research 1987 30 197 206
11. Sapienza CM Walton S Murry T Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading Journal of Voice 2000 14 502 520
12. Schaefer S Freeman F Finitzo T et al. Magnetic resonance imaging findings and correlations in spasmodic dysphonia patients Annals of Otology Rhinology and Laryngology 1985 94 595 601
13. Aronson AE Lagerlund TD Neuroimaging studies do not prove the existence of brain abnormalities in spastic (spasmodic) dysphonia Journal of Speech and Hearing Research 1991 34 801 811
14. Watson BC Freeman FJ Pool KD et al. Laryngeal reaction time profiles in spasmodic dysphonia: relationship to cortical electrophysiologic abnormality Journal of Speech and Hearing Research 1991 34 269 278
15. Yamamoto T Yamashita M Thalamo-olivary degeneration in a patient with laryngopharyngeal dystonia Journal of Neurology Neurosurgery and Psychiatry 1995 59 438 441
16. Devous MD Sr. Pool KD Finitzo T et al. Evidence for cortical dysfunction in spasmodic dysphonia: regional cerebral blood flow and quantitative electrophysiology Brain and Language 1990 39 331 344
17. Hirano S Kojima H Naito Y et al. Cortical dysfunction of the supplementary motor area in a spasmodic dysphonia patient American Journal of Otolaryngology 2001 22 219 222
18. Ludlow CL Schulz GM Yamashita T Deleyiannis FW Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia Annals of Otology Rhinology and Laryngology 1995 104 928 935
19. Deleyiannis FW Gillespie M Bielamowicz S Yamashita T Ludlow CL Laryngeal long latency response conditioning in abductor spasmodic dysphonia Annals of Otology Rhinology and Laryngology 1999 108 612 619
20. Blitzer A Brin MF Fahn S Lange D Lovelace RE Botulinum toxin (BOTOX) for the treatment of ''spastic dysphonia'' as part of a trial of toxin injections for the treatment of other cranial dystonias Laryngoscope 1986 96 1300 1301
21. Frueh BR Felt DP Wojno TH Musch DC Treatment of blepharospasm with botulinum toxin. A preliminary report Archives of Ophthalmology 1984 102 1464 1468
22. Tsui JK Eisen A Mak E Carruthers J Scott A Calne DB A pilot study on the use of botulinum toxin in spasmodic torticollis Canadian Journal of Neurological Sciences 1985 12 314 316
23. Tsui JK Eisen A Stoessl AJ Calne S Calne DB Double-blind study of botulinum toxin in spasmodic torticollis Lancet 1986 2 245 247
24. Blitzer A Brin MF Fahn S Lovelace RE Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia) Laryngoscope 1988 98 193 197
25. Troung DD Rontal M Rolnick M Aronson AE Mistura K Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia Laryngoscope 1991 101 630 634
26. Boutsen F Cannito MP Taylor M Bender B Botox treatment in adductor spasmodic dysphonia: a meta-analysis Journal of Speech Language and Hearing Research 2002 45 469 481
27. Watts CC Whurr R Nye C Botulinum toxin injections for the treatment of spasmodic dysphonia Cochrane Database Systematic Reviews: 2002 CD004327
28. Whurr R Nye C Lorch M Meta-analysis of botulinum toxin treatment of spasmodic dysphonia: a review of 22 studies International Journal of Language and Communication Disorders 1998 33 Suppl. 327 329
29. Brin MF Blitzer A Stewart C Laryngeal dystonia (spasmodic dysphonia): observations of 901 patients and treatment with botulinum toxin Advances in Neurology 1988 78 237 252
30. Blitzer A Brin MF Stewart CF Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients Laryngoscope 1998 108 1435 1441
31. Ludlow CL Naunton RF Sedory SE Schulz GM Hallett M Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia Neurology 1988 38 1220 1225
32. Klotz DA Maronian NC Waugh PF Shahinfar A Robinson L Hillel AD Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography Annals of Otology Rhinology and Laryngology 2004 113 602 612
33. Bielamowicz S Stager SV Badillo A Godlewski A Unilateral versus bilateral injections of botulinum toxin in patients with adductor spasmodic dysphonia Journal of Voice 2002 16 117 123
34. Koriwchak MJ Netterville JL Snowden T Courey M Ossoff RH Alternating unilateral botulinum toxin type A (BOTOX) injections for spasmodic dysphonia Laryngoscope 1996 106 1476 1481
35. Maloney AP Morrison MD A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia Journal of Otolaryngology 1994 23 160 164
36. Miller RH Woodson GE Jankovic J Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report Archives of Otolaryngology Head and Neck Surgery 1987 113 603 605
37. Ford CN Bless DM Lowery JD Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia Otolaryngology Head and Neck Surgery 1990 103 752 758
38. Rhew K Fiedler DA Ludlow CL Technique for injection of botulinum toxin through the flexible nasolaryngoscope Otolaryngology Head and Neck Surgery 1994 111 787 794
39. Green DC Berke GS Ward PH Gerratt BR Point-touch technique of botulinum toxin injection for the treatment of spasmodic dysphonia Annals of Otology Rhinology and Laryngology 1992 101 883 887
40. Brin MF Blitzer A Fahn S Gould W Lovelace RE Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox) Movement Disorders 1989 4 287 296
41. Garcia Ruiz PJ Cenjor Espanol C Sanchez Bernardos V Astarloa R Sanabria J Garcia de Yebenes J Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach Clinical Neuropharmacology 1998 21 196 198
42. Sataloff RT Mandel S Mann EA Ludlow CL Laryngeal electromyography: an evidence-based review Muscle and Nerve 2003 28 767 772
43. Odergren T Hjaltason H Kaakkola S et al. A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia Journal of Neurology Neurosurgery and Psychiatry 1988 64 6 12
44. Van den Bergh PY Lison DF Dose standardization of botulinum toxin Advances in Neurology 1988 78 231 235
45. Marion MH Sheehy M Sangla S Soulayrol S Dose standardisation of botulinum toxin Journal of Neurology Neurosurgery and Psychiatry 1995 59 102 103
46. Poewe W Respective potencies of Botox® and Dysport®: a double blind, randomised, crossover study in cervical dystonia Journal of Neurology Neurosurgery and Psychiatry 2002 72 430
47. Ranoux D Gury C Fondarai J Mas JL Zuber M Respective potencies of Botox® and Dysport®: a double blind, randomised, crossover study in cervical dystonia Journal of Neurology Neurosurgery and Psychiatry 2002 72 459 462
48. Brashear A Lew MF Dykstra DD et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia Neurology 1999 53 1439 1446
49. Brin MF Lew MF Adler CH et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia Neurology 1999 53 1431 1438
50. Dressler D Adib Saberi F Benecke R Botulinum toxin type B for treatment of axillar hyperhidrosis Journal of Neurology 2002 249 1729 1732
51. Dressler D Bigalke H Antibody-induced failure of botulinum toxin type B therapy in de novo patients European Neurology 2004 52 132 135
52. Brin MF Fahn S Moskowitz C et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm Advances in Neurology 1988 50 599 608
53. Jankovic J Schwartz K Donovan DT Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm Journal of Neurology Neurosurgery and Psychiatry 1990 53 633 639
54. Blitzer A Sulica L Botulinum toxin: basic science and clinical uses in otolaryngology Laryngoscope 2001 111 218 226
55. Guntinas-Lichius O Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A Laryngoscope 2003 113 743 745
56. Adler CH Bansberg SF Krein-Jones K Hentz JG Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia Movement Disorders 2004 19 1075 1079
57. Blitzer A Brin MF Stewart C Aviv JE Fahn S Abductor laryngeal dystonia: a series treated with botulinum toxin Laryngoscope 1992 102 163 167
58. Rontal M Rontal E Rolnick M Merson R Silverman B Truong DD A method for the treatment of abductor spasmodic dysphonia with botulinum toxin injections: a preliminary report Laryngoscope 1991 101 911 914
59. Meleca RJ Hogikyan ND Bastian RW A comparison of methods of botulinum toxin injection for abductory spasmodic dysphonia Otolaryngology Head and Neck Surgery 1997 117 487 492
60. Zwirner P Dressler D Kruse E Spasmodic laryngeal dyspnea: a rare manifestation of laryngeal dystonia European Archives of Otorhinolaryngology 1997 254 242 245
61. Koda J Ludlow CL An evaluation of laryngeal muscle activation in patients with voice tremor Otolaryngology Head and Neck Surgery 1992 107 684 696
62. Warrick P Dromey C Irish JC Durkin L Pakiam A Lang A Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection Laryngoscope 2000 110 1366 1374
63. Adler CH Bansberg SF Hentz JG et al. Botulinum toxin type A for treating voice tremor Archives of Neurology 2004 61 1416 1420
64. Warrick P Dromey C Irish J Durkin L The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report Journal of Voice 2000 14 410 421
65. Adler CH Bansberg SF Hentz JG et al. Botulinum toxin type A for treating voice tremor Archives of Neurology 2004 61 1416 1420